For example, high CD8+ T cell, CD8+ T cell/TB, and CD8+ T cell/CSC indices predicted an active anti-tumor immune microenvironment, which was suitable for a checkpoint regimen, such as PD-1/PD-L1 Tim-3 blockade, and a CD40 agonist40. This evidence concerns the gene CD8A and neoplasm.